Sex Hormone Levels, Breast Cancer Risk, and Cancer Receptor Status in Postmenopausal Women: the ORDET Cohort

被引:96
|
作者
Sieri, Sabina [1 ]
Krogh, Vittorio [1 ]
Bolelli, Gianfranco [7 ]
Abagnato, Carlo Alberto [7 ]
Grioni, Sara [1 ]
Pala, Valeria [1 ]
Evangelista, Alberto [1 ]
Allemani, Claudia [2 ]
Micheli, Andrea [3 ]
Tagliabue, Giovanna [4 ]
Schunemann, Holger J. [8 ]
Menard, Sylvie [5 ]
Berrino, Franco [6 ]
Muti, Paola [8 ]
机构
[1] Fdn IRCCS Ist Nazl Tumori, Nutr Epidemiol Unit, I-20133 Milan, Italy
[2] Fdn IRCCS Ist Nazl Tumori, Analyt Epidemiol Unit, I-20133 Milan, Italy
[3] Fdn IRCCS Ist Nazl Tumori, Descript Epidemiol & Hlth Planning Unit, I-20133 Milan, Italy
[4] Fdn IRCCS Ist Nazl Tumori, Canc Registry Div, I-20133 Milan, Italy
[5] Fdn IRCCS Ist Nazl Tumori, Labs & Dept Expt Oncol, Mol Biol Unit, I-20133 Milan, Italy
[6] Fdn IRCCS Ist Nazl Tumori, Etiol & Prevent Epidemiol Unit, I-20133 Milan, Italy
[7] Ctr Med Diagnost Emilia, Bologna, Italy
[8] Ist Regina Elena, Epidemiol & Prevent Unit, I-00161 Rome, Italy
关键词
METABOLIC-SYNDROME; ESTROGEN-RECEPTOR; GENE-EXPRESSION; ENDOGENOUS ESTROGENS; PROGESTERONE; ANDROGEN; TESTOSTERONE; CARCINOMAS; GROWTH;
D O I
10.1158/1055-9965.EPI-08-0808
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Endogenous sex hormone levels have been associated with increased breast cancer risk in postmenopausal women in several prospective studies. However, it remains unclear to what extent serum hormone-breast cancer associations differ with receptor status. Methods: Associations between serum sex hormone levels and breast cancer risk were assessed in a nested case-control study on postmenopausal women of the ORDET cohort. After a median follow-up of 13.5 years, 1.65 women developed breast cancer. Relative risks of developing breast cancer were estimated by conditional logistic regression. Results: Total and free testosterone levels were directly associated with breast cancer risk [relative risk, 3.28 (95% confidence interval, 1.93-5.55) and 2.86 (95% confidence interval, 1.66-4.94), respectively, for highest versus lowest quartile]. When relations between hormone level and risk of breast cancer expressing various receptor combinations were assessed, high total testosterone was significantly associated with increased risk of estrogen receptor-positive cancers, irrespective of progesterone receptor status. High total testosterone was also associated with increased risk of both human epidermal growth factor receptor 2 (HER2)-negative (HER2(-)) and HER2(+) cancers. High estradiol tended to be associated with increased risk of HER2- cancer and inversely associated with HER2(+) cancer, with significant (P = 0.027) heterogeneity between HER2(+) and HER2- cancers. However, there were relatively few HER2(+) cases. Conclusions: This study provides further evidence that high levels of circulating testosterone increase the risk of developing breast cancer in postmenopausal women. The cancers that develop are mainly estrogen receptor positive. Although HER2(+) and HER2- breast cancers were both associated with high total testosterone, they showed opposing associations with estrogen. (Cancer Epidemiol Biomarkers Prev 2009;18(1):169-76)
引用
收藏
页码:169 / 176
页数:8
相关论文
共 50 条
  • [21] Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status-Results from the EPIC cohort
    Kaaks, Rudolf
    Tikk, Kaja
    Sookthai, Disorn
    Schock, Helena
    Johnson, Theron
    Tjonneland, Anne
    Olsen, Anja
    Overvad, Kim
    Clavel-Chapelon, Francoise
    Dossus, Laure
    Baglietto, Laura
    Rinaldi, Sabina
    Chajes, Veronique
    Romieu, Isabelle
    Boeing, Heiner
    Schuetze, Madlen
    Trichopoulou, Antonia
    Lagiou, Pagona
    Trichopoulos, Dimitrios
    Palli, Domenico
    Sieri, Sabina
    Tumino, Rosario
    Ricceri, Fulvio
    Mattiello, Amalia
    Buckland, Genevieve
    Ramon Quiros, Jose
    Sanchez, Maria-Jose
    Amiano, Pilar
    Chirlaque, Maria-Dolores
    Barricarte, Aurelio
    Bas Bueno-de-Mesquita, H.
    van Gils, Carla H.
    Peeters, Petra H.
    Andersson, Anne
    Sund, Malin
    Weiderpass, Elisabete
    Khaw, Kay-Tee
    Wareham, Nick
    Key, Timothy J.
    Travis, Ruth C.
    Merritt, Melissa A.
    Gunter, Marc J.
    Riboli, Elio
    Lukanova, Annekatrin
    INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (08) : 1947 - 1957
  • [22] A Prospective Evaluation of Endogenous Sex Hormone Levels and Colorectal Cancer Risk in Postmenopausal Women
    Murphy, Neil
    Strickler, Howard D.
    Stanczyk, Frank Z.
    Xue, Xiaonan
    Wassertheil-Smoller, Sylvia
    Rohan, Thomas E.
    Ho, Gloria Y. F.
    Anderson, Garnet L.
    Potter, John D.
    Gunter, Marc J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (10):
  • [23] Androgen receptors and sex hormone serum levels in breast carcinoma: Study of the ORDET cohort
    Cimetti, L.
    Sieri, S.
    Chiaravalli, A. M.
    Sahnane, N.
    Sessa, F.
    Riva, C.
    Capella, C.
    VIRCHOWS ARCHIV, 2012, 461 : S237 - S237
  • [24] Statins and breast cancer risk in a cohort of postmenopausal women
    Dossus, Laure
    Chajes, Veronique
    His, Mathilde
    Cairat, Manon
    Al-Rahmoun, Marie
    Fagherazzi, Guy
    Severi, Gianluca
    Gunter, Marc J.
    Fournier, Agnes
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 572 - 572
  • [25] Intake of whole grain products and risk of breast cancer by hormone receptor status and histology among postmenopausal women
    Egeberg, Rikke
    Olsen, Anja
    Loft, Steffen
    Christensen, Lane
    Johnsen, Nina Fons
    Overvad, Kim
    Tjonneland, Anne
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (03) : 745 - 750
  • [26] Dietary lignans and postmenopausal breast cancer risk by oestrogen receptor status: a prospective cohort study of Swedish women
    R Suzuki
    T Rylander-Rudqvist
    S Saji
    L Bergkvist
    H Adlercreutz
    A Wolk
    British Journal of Cancer, 2008, 98 : 636 - 640
  • [27] Dietary lignans and postmenopausal breast cancer risk by oestrogen receptor status: a prospective cohort study of Swedish women
    Suzuki, R.
    Rylander-Rudqvist, T.
    Saji, S.
    Bergkvist, L.
    Adlercreutz, H.
    Wolk, A.
    BRITISH JOURNAL OF CANCER, 2008, 98 (03) : 636 - 640
  • [28] Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status
    Bardia, Aditya
    Hartmann, Lynn C.
    Vachon, Celine M.
    Vierkant, Robert A.
    Wang, Alice H.
    Olson, Janet E.
    Sellers, Thomas A.
    Cerhan, James R.
    ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (22) : 2478 - 2483
  • [29] Plasma sex hormone concentrations and breast cancer risk in an ethnically diverse population of postmenopausal women: the Multiethnic Cohort Study
    Woolcott, Christy G.
    Shvetsov, Yurii B.
    Stanczyk, Frank Z.
    Wilkens, Lynne R.
    White, Kami K.
    Caberto, Christian
    Henderson, Brian E.
    Le Marchand, Loic
    Kolonel, Laurence N.
    Goodman, Marc T.
    ENDOCRINE-RELATED CANCER, 2010, 17 (01) : 125 - 134
  • [30] Postmenopausal hormone therapy and breast cancer risk: The Multiethnic Cohort
    Lee, S
    Kolonel, L
    Wilkens, L
    Wan, P
    Henderson, B
    Pike, M
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (05) : 1285 - 1291